These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1145 related articles for article (PubMed ID: 19408049)

  • 1. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
    Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
    Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
    J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
    Yang XJ; Li Y; Yonemura Y
    J Surg Oncol; 2010 May; 101(6):457-64. PubMed ID: 20401915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
    Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
    Brigand C; Monneuse O; Mohamed F; Sayag-Beaujard AC; Isaac S; Gilly FN; Glehen O
    Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
    Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
    Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kusamura S; Baratti D; Antonucci A; Younan R; Laterza B; Oliva GD; Gavazzi C; Deraco M
    Ann Surg Oncol; 2007 Dec; 14(12):3443-52. PubMed ID: 17909918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.
    Spiliotis J; Tentes AA; Vaxevanidou A; Korakianitis OS; Rogdakis A; Mirelis CG; Datsis AC; Kekelos S
    J BUON; 2008; 13(2):205-10. PubMed ID: 18555466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
    Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
    Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
    Kusamura S; Baratti D; Younan R; Laterza B; Oliva GD; Costanzo P; Favaro M; Gavazzi C; Grosso F; Deraco M
    Ann Surg Oncol; 2007 Sep; 14(9):2550-8. PubMed ID: 17558537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis.
    Capone A; Valle M; Proietti F; Federici O; Garofalo A; Petrosillo N
    J Surg Oncol; 2007 Nov; 96(6):507-13. PubMed ID: 17708508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
    Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
    Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S; Deraco M; Baratti D; Inglese MG; Costanzo P; Favaro M; Manzi R; Gavazzi C
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):207-12. PubMed ID: 16767933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Updated treatment of peritoneal carcinomas: a review].
    Deraco M; Laterza B; Kusamura S; Baratti D
    Minerva Chir; 2007 Dec; 62(6):459-76. PubMed ID: 18091656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center.
    Gusani NJ; Cho SW; Colovos C; Seo S; Franko J; Richard SD; Edwards RP; Brown CK; Holtzman MP; Zeh HJ; Bartlett DL
    Ann Surg Oncol; 2008 Mar; 15(3):754-63. PubMed ID: 18080166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.